Sinopharm Group Co. Ltd. (FRA:X2S1)

Market Cap	7.11B -9.1%
Revenue (ttm)	68.67B -3.3%
Net Income	847.35M -14.1%
EPS	0.27 -13.7%
Shares Out	n/a
PE Ratio	8.39
Forward PE	7.47
Dividend	0.30 (2.67%)
Ex-Dividend Date	Jun 17, 2025

Volume	n/a
Average Volume	n/a
Open	11.60
Previous Close	11.60
Day's Range	11.60 - 11.60
52-Week Range	9.55 - 12.50
Beta	n/a
RSI	64.48
Earnings Date	Mar 27, 2026

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 108,217
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X2S1

Financial Performance

In 2024, Sinopharm Group's revenue was 584.51 billion, a decrease of -2.02% compared to the previous year's 596.57 billion. Earnings were 7.05 billion, a decrease of -22.14%.

Financial numbers in CNY